US Patent 7716030 Target ligand generation
Patent 7716030 was granted and assigned to Vertex Pharmaceuticals on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+381 characters)
Article
Patent abstract
Methods of identifying potential ligands for macromolecular targets are disclosed herein. The methods comprise providing models of three dimensional structural information for ligands or a ligand:macromolecule complex, mapping spatial relationships between the models, and identifying one or more pairs of matching bonds. Databases and apparatuses are also provided.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07716030 Target ligand generation US Patent 7716030 Target ligand generation
Infobox
Patent Number
0771603000
Patent Number
771603000
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077160300
Date of Patent
May 11, 2010
0Patent Application Number
107905070
Date Filed
March 1, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077160300
Date of Patent
May 11, 2010
0Patent Application Number
107905070
Date Filed
March 1, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07716030 Target ligand generation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07716030
Date of patent
May 11, 2010
Patent application number
10790507
Date Filed
March 1, 2004
Patent primary examiner
Find more entities like US Patent 7716030 Target ligand generation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
